Dominique Grillet
Endocrinology
Gastroenterology / Hepatology
Immunology
Infectious Diseases - Vaccines
Ivd / Diagnostics
Nutrition and Weight Loss
Oncology
Pulmonary/Respiratory Diseases
Rare Disease
Rheumatology
Your innovative solution
As a part of our advanced concept and system combining mobile hardware with sensor, smarts of software engines capabilities and personalized dashboard; our exclusive & patented BIA measurement & analysis offers a direct valuation of body composition, hydration and nutrition status at one glance.
Our unique
Health/weight management/Sport/Seniors/
Connected Device & cloud based engine & storage technology/ The only one in this range of product to deliver instantly full body composition analysis/ Accurate & reliable / Highly personalizable and flexible
BBRC-Aminogram
Manager directeurLuc Grislain
BERTIN PHARMA Bertin Pharma, a specialty CRO offering DRUG DELIVERY SYSTEMS solutions from NCE to OTC in a life cycle management oriented mind Industry sectors BioPharma Therapeutics Area Cardiology / Vascular Diseases
CNS-Neurology
Dental and Oral Health
Dermatology
Endocrinology
Gastroenterology / Hepatology
Immunology
Infectious Diseases - Vaccines
Obstetrics/Gynecology (Women's Health)
Oncology
Ophthalmology
Orthopedics/Orthopedic Surgery
Otolaryngology (Ear, Nose, Throat)
Pediatrics/Neonatology
Pulmonary/Respiratory Diseases
Rare Disease
Psychiatry/Psychology
Rheumatology
Your innovative solution
Bertin Pharma recently integrates one of the most outstanding GMP facilities in Europe specifically dedicated to the Pharmaceutical development of OTC. A large panel of original Drug Delivery Systems particularly suitable to fit the OTC needs with optimized sensorial attributes are available. Among them Dualtab
DUALTAB
Ethics (NCEs & Biologics), OTC, Generic plus
Quick local symptoms relief Dual action quick and long lasting Product design makes dual action visible for patients Robust manufacturing process and low industrial cost price
Bertin Pharma
Co-founderDr Marc Grodman
BioReference is the third largest full service clinical diagnostic laboratory in the U.S. providing testing and related services to physician offices, clinics, hospitals, long term care facilities, employers, governmental units and correctional institutions. We offer a comprehensive test list focusing on molecular diagnostics, anatomical pathology, genetics, and women’s health. Moreover, through its GeneDx subsidiary, BioReference has an international presence in more than 50 countries around the world.
Our client retention is unparalleled in the industry because we are much more than just the provider of quality diagnostics. We have grown primarily as a result of our differentiating business model which is both physician-centric – providing superior service and support – and clinically relevant – providing innovative and disruptive technology to improve patient outcomes. What makes us different from other labs is the added value we bring through personal attention and professional support and the effort we make to understand our clients’ needs. Our success comes from helping clinicians deliver premium services to the patients in their care – through a full menu of cost–conscious testing options and cutting edge technologies with clinically–relevant results, all in a medically and fiscally responsible manner.
In addition, BioReference has pioneered the development of business solutions for our clients, providing data and analytics to help them operate at their fullest potential.
The Laboratory services multiple markets through several specialized business units, each with its own dedicated sales team and highly-trained support personnel. These include women’s health, oncology, genetics and a lab division focused exclusively on the nation’s expanding Spanish-speaking populations.
Clinical Diagnostics, Oncology, Women's Health, Genetic Testing
BioReference Laboratories
MDMs Lauren Grosz
The American Heart Association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. Founded by six cardiologists in 1924, our organization now includes more than 22.5 million volunteers and supporters. We fund innovative research, fight for stronger public health policies, and provide critical tools and information to save and improve lives. Our nationwide organization includes 156 local offices and more than 3,000 employees. We moved our national headquarters from New York to Dallas in 1975 to be more centrally located. The American Stroke Association was created as a division in 1997 to bring together the organization’s stroke-related activities.
What We Do: To improve the lives of all Americans, we provide public health education in a variety of ways. We’re the nation’s leader in CPR education training. We help people understand the importance of healthy lifestyle choices. We provide science-based treatment guidelines to healthcare professionals to help them provide quality care to their patients. We educate lawmakers, policymakers and the public as we advocate for changes to protect and improve the health of our communities.
American Heart Association
Director of DevelopmentFrederic Guibet
CTEXDEV develops Augmentative and Alternative Communication (AAC) applications called CommunicoTool, to help non-verbal individuals to communicate.
Industry sectors E_healthOur innovative solution
CommunicoTool is an Augmentative and Alternative Communication (AAC) application that provide language communication features including: pictures and pictograms, prerecorded voice, speech synthesis, speech/pain assessment, time management. The application is fully configurable by the end users. Our service is available in French and English in a bilingual version.
Problem solvedCommunicoTool is an application for tablets suitable for patients with ASD, Stroke, LAS, Cerebral pulsy, with language and communication disorders. Just for ASD, The CDC (Centers for Disease Control and Prevention) estimates about 1 percent of the world population (7 billion) has autism spectrum disorder, and more than 25% of them are non-verbal.
ASD / Stroke / LAS / Cerebral pulsy
Accessibility / price / Innovation / Configurable
C. Texdev
CEO - FounderMr OLIVE Guillaume
Your innovative solution
UrgoTouch is the first preventive laser which significantly improves the post-operative scar aesthetic and functional results.
Today, there is no good way to prevent unsightly scars: there should be a solution that would give more control over the scar aesthetic and functional results.
1) Aesthetics surgeons and any surgeon looking to deliver a functional and aesthetic scar after surgery
2) Aesthetics dermatologists for small operations in their office
Key value proposition1) High level of research, development and clinical performance
2) Restoring patients former quality of life
3) Innnovative breakthrough for a large patient demand
4) Bring Urgo medical grade expertise in skin and healing to the aesthetic market
Urgo Medical
Business Development ManagerMr Pradeep Gupte
Rockland Technimed Limited is a diagnostic imaging company, committed to the early diagnosis and treatment of ischemic injury, through its patented Oxy-17® metabolic magnetic resonance imaging medium.
Rockland Technimed Limited (RTL) is a theranostic imaging company committed to the early diagnosis and treatment of hypoxic injury through Oxy-17®, its patented metabolic magnetic resonance imaging medium. RTL has the world’s largest production source of Oxy-17® Gas, an enriched form of naturally available oxygen, in compliance with the cGMP requirement for medical gases, and commercially available in the United States and European Union for more than 20 years. RTL’s lead preclinical candidate, Oxy-17® Fusion, is the first ready-to-use intravenous formulation of Oxy-17® Gas and is currently in regulatory marketing studies in Germany (European Union) and the United States. Oxy-17® Fusion will be commercialized in the United States by RTL, and in the European Union with Nukem Isotopes GmbH.Rockland Technimed Ltd
Founder & CEOMr Dane Hamilton
The insight you’ll gain from Mergermarket often doesn’t become public knowledge until 6-24 months after our journalists first report on it, giving you a large window of opportunity to take early action.
Our global team of dedicated M&A journalists uses its extensive network of industry contacts and executives to gather information about corporate strategy, providing a unique source of M&A intelligence.
League tablesBecause we’re always up to speed on which advisors are working which M&A deals, our detailed ‘Who’s who in M&A’ league tables have become an industry standard among investment professionals.
As a Mergermarket subscriber, you can custom-build individual or house league tables to analyze firm performance and enhance your marketing, competitor analysis or pitch book efforts.
ECMOur new ECM tab is more than just an origination tool. It’s an independent voice, delivering the ECM news and information you need, ahead of the market. Learn more about Mergermarket ECM.
Analysis
Our multilingual team of journalists monitors more than 3,000 global media sources daily, summarizing the most relevant stories to supplement the information our correspondents provide.
Deals databaseThrough Mergermarket, you can search a global library of historical M&A transactions with fully sourced financials and exit multiples. You can analyze volumes and values of M&A activity in specific regions or sectors to discover deal patterns and identify trends ahead of competitors.
Private equity portfolioUsing Mergermarket’s customizable Private Equity Search facility, you can analyze over 1,000 of the world’s biggest private equity firms, looking at current portfolio, historical exits, potential investments, firm profile, historical advisor and investment relationships, and rival bidders.
What our subscribers say
-
"Being an international law firm, we value Mergermarket as an important resource for real time deal intelligence across borders."
Dechert LL
Scott A. Hansen
Your healthcare business faces pressures far beyond escalating costs and competition. Complex regulations now require that you search for efficiencies, seek new ways to offer your services and migrate from paper to electronic data processing.
J.P. Morgan can help you meet those goals. For more than 30 years, we have worked with hospitals and health systems, insurers, private practices and nursing homes. Today, we serve:
- More than 1,100 hospitals,
- 10 of the top 10 health insurers,
- Thousands of physicians’ groups, third-party administrators and other healthcare organizations,
- The top five pharmacy benefit managers and
- Six of the top eight pharmacy retailers.
Our treasury products and services can help you accelerate cash flow and optimize your organization’s working capital. In addition, by using products we have specifically designed for the healthcare industry, you can improve the accuracy of the information you need for efficient payment and remittance processing. To learn more about these products, including Healthcare Link for Payers, Healthcare Link for Providers and Health Savings Accounts, see below.
Whether you are coping with the impact of healthcare reform, trying to reduce costs, seeking to improve margins or trying to increase your working capital, put the experience and knowledge of J.P. Morgan Treasury Services to work for your organization.
Healthcare LinkSMFacilitate the movement from paper to electronic claim remittance processing. Our solution automates the capture and passage of electronic files of explanations of benefits (EOBs) for faster, more accurate posting into your patient accounting or practice management system while still supporting legacy paper processes. See how it can help you.